Loading clinical trials...

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT00486278

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

This trial is conducted in Africa, Asia, Europe, Japan, and North and South America. The aim of this trial is to evaluate the safety and efficacy of activated recombinant human factor VII analogue (v...

Lead sponsor: Novo Nordisk A/S•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

NCT03695978 · Haemophilia A

RECRUITINGPhase 3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814 · Haemophilia A (Moderate or Severe)

RECRUITINGPhase 3

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

NCT07437404 · Haemophilia A

RECRUITING

Prevalence of Synovitis in Patients With Haemophilia A

NCT06352216 · Haemophilia A, Synovitis, and more

Enrolling By Invitation

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

NCT06831734 · Haemophilia A, Haemophilia B

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 7, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment51

Start dateJun 2007

Last updatedMar 7, 2017

Condition

Congenital Bleeding Disorder Haemophilia A Haemophilia B

Locations shown

Novo Nordisk Investigational Site

Los Angeles, California

Novo Nordisk Investigational Site

Augusta, Georgia

Novo Nordisk Investigational Site

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 7, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

Prevalence of Synovitis in Patients With Haemophilia A

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Trial snapshot

Condition

Locations shown

For caregivers